AAPGV: Ascentage Pharma Group International Book Value of Business

Public company logo of Ascentage Pharma (AAPGV)

The price history of Ascentage Pharma Group (AAPGV) reflects the dynamics of an asset whose business relies on strict temperature monitoring during the transport of advanced medications. The current indicator is 0.05. Ascentage Pharma Group is implementing robotics to accelerate the selection of molecules that block tumor proteins. High authority among physicians and global medical partnerships strengthen shareholder confidence in the success of the therapies under development.

AAPGV Ascentage Pharma Group Book Capitalization (01/25/2025 - 10/28/2026)

Analytical breakdowns and data insights for company Ascentage Pharma (AAPGV)

- price and consensus price forecast:
Quote Chart Ascentage|AAPGV - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Ascentage Pharma Group International|AAPGV - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share Ascentage Pharma|AAPGV - Book Capitalization|Market Cap to Net Assets Ratio ascentage.com|AAPGV - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Ascentage Pharma Group|AAPGV - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Ascentage Pharma Group International|AAPGV - Company Aggregate Debts|Debt to Book Value Ascentage Pharma Group International|AAPGV - Company Long-Term Debts|Short-Term Debt Ascentage Pharma
Fundamental valuation:AAPGV - Ascentage
Flagship merchandise of Ascentage

This indicator reflects the real value of the business through the difference between net assets and debt obligations, allowing the investor to assess internal financial stability and capital protection against bankruptcy. For Ascentage Pharma Group (AAPGV), such a foundation is critical when scaling the pipeline and entering the US market with olverematinib, which the book value dynamics clearly confirm.

Key competitors

ONC - Net Asset Value|Book Capitalization HALO (Halozyme Therapeutics)|Book Value of Business revmed.com|Company Net Assets Ascentage Pharma|Company Book Value CG Oncology Inc|Book Capitalization URGN (UroGen)|Company Net Assets Bicara Corp (BCAX)|Book Capitalization PSNL (Personalis, Inc.)|erasca.com - Book Capitalization|Delcath Systems (DCTH) - Company Book Value|YMAB - Accounting Capitalization|AURA (Aura Bio) - Book Capitalization|Candel Therapeutics, Inc. (CADL) - Company Net Assets|Book Capitalization ARAY (Accuray Incorporated)|Total Stockholders' Equity SLS|Actuate Therapeutics (ACTU) - Company Book Value|Accounting Value of Company Citius Oncology Inc. CTOR|Company Net Assets TuHURA Biosciences|Accounting Value of Company Protara Tx TARA|FATE: Book Capitalization|Aadi Bioscience Inc (WHWK) - Company Net Assets|TCRX: Company Net Assets|CSBR (Champions Oncology, Inc.) - Book Capitalization|XBIT - Company Book Value|Accounting Value of Company CEL-SCI Corp|OS Therapies Incorporated - Book Capitalization|Total Stockholders' Equity Radiopharm Theranostics Ltd (RADX)|Book Capitalization ARTV (Artiva Biotherapeutics)|Adlai Nortye Ltd - Book Capitalization|Company Book Value VERU (Veru Pharma)|TPST - Book Valuation of Business|XLO (xiliotx.com) - Book Capitalization|Renovaro (RENB) - Company Net Assets|Book Capitalization MURA (Mural Oncology PLC)|Total Stockholders' Equity KAPA|Company Book Value OnKure Therapeutics Inc OKUR|Accounting Capitalization w2.cytomed.sg GDTC|Company Net Assets Curis (CRIS)|Total Net Assets Apollomics Inc. APLM|Tharimmune - Book Capitalization|ADVB - Book Capitalization|Book Capitalization GNPX (Genprex, Inc)|Calidi Biotherapeutics, Inc. (CLDI) - Book Value of Business|Book Capitalization SBFM (Sunshine Biopharma)|Total Stockholders' Equity Xenetic Bio (XBIO)|Salarius Pharmaceuticals, Inc. (SLRX) - Company Net Assets|Accounting Value of Company PPBT (Purple Biotech Ltd)|American Oncology Network, Inc. (AONC) - Company Book Value|Net Asset Value BeiGene Ltd BGNE|Book Capitalization Checkpoint Therapeutics (CKPT)|ELEV - Accounting Value of Company|ICAD: Book Capitalization|IKNA (Ikena Oncology) - Book Capitalization|NTBL - Company Book Value|Accounting Value of Company VIRX|Company Book Value MOR (MorphoSys AG)|Company Net Assets nayabiosciences.com (NAYA)